Willkie Farr & Gallagher advised SGT, and Goodwin advised Summit Partners. SGT Capital announced that it has reached a definitive agreement to acquire Elatec GmbH from growth equity...
You must be a Standard 1 Year member to access this content.
Goodwin advised GaeaStar on the deal. GaeaStar announced its $6.5 million seed funding round. The round was led by a family office focused on ethical investments and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
You must be a Standard 1 Year member to access this content.
Goodwin advised TowerBrook on the deal. TowerBrook Capital Partners (“TowerBrook”) announced its acquisition of a majority stake in TXO, a provider of telecom network hardware and asset...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised PointClickCare Corp. on the deal. PointClickCare Corp. announced its acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies’...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SonoThera, Inc. on the deal. SonoThera, Inc. announced its $60.75 million Series A financing round to support the continued development of SonoThera’s ultrasound-guided, nonviral,...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb represented Takeda in the transaction while Goodwin Procter advised Nimbus Therapeutics. Takeda (TSE:4502/NYSE:TAK) announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised PTC on the deal, Ropes & Gray represented ServiceMax, Latham & Watkins represented Centerview Partners. PTC (NASDAQ: PTC) signed its definitive agreement to acquire...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CathWorks on the deal. CathWorks announced its acquisition option agreement and co-promotion agreement with Medtronic (NYSE: MDT). Under the acquisition option agreement, Medtronic will...
You must be a Standard 1 Year member to access this content.
Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Cast & Crew in the transaction while Goodwin advised TA Associates and Backstage Holdings. Cast & Crew, a leading end-to-end cloud-based platform...
You must be a Standard 1 Year member to access this content.
